Company Filing History:
Years Active: 2016-2022
Title: Mark R Frey: Innovator in Medical Treatments
Introduction
Mark R Frey is a notable inventor based in Glendale, CA (US). He has made significant contributions to the field of medical treatments, particularly in relation to diseases mediated by ERBB4-positive pro-inflammatory macrophages. With a total of 4 patents, Frey continues to push the boundaries of innovation in healthcare.
Latest Patents
Frey's latest patents include methods for treating diseases associated with increased numbers of ErbB4+ pro-inflammatory macrophages. These methods involve providing an activator of ErbB4 and administering a therapeutically effective amount to the subject. One of the key components in this process is Neuregulin-4, which plays a crucial role in activating ERBB4. Additionally, he has developed an ERBB4 activator screening assay, which provides methods and pharmaceutical compositions for treating inflammatory bowel disease and necrotizing enterocolitis by administering an effective amount of a composition that includes an activator of ERBB4.
Career Highlights
Mark R Frey is affiliated with Children's Hospital Los Angeles, where he applies his expertise in medical research and innovation. His work focuses on developing new therapeutic strategies to improve patient outcomes in various disease states.
Collaborations
Frey collaborates with several professionals in the field, including his coworker Michael Schumacher. Their combined efforts contribute to advancing medical research and treatment methodologies.
Conclusion
Mark R Frey is a dedicated inventor whose work in medical treatments showcases his commitment to improving healthcare. His innovative patents and collaborations highlight the importance of research in addressing complex medical challenges.